Therapeutic Targeting of Classical and Lectin Pathways of Complement Protects from Ischemia-Reperfusion-Induced Renal Damage
- 1 April 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (4) , 1648-1659
- https://doi.org/10.2353/ajpath.2010.090276
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Biological activities of C1 inhibitorMolecular Immunology, 2008
- Therapeutic Interventions Favorably Influencing Delayed and Slow Graft Function in Kidney Transplantation: Mission Impossible?Transplantation, 2008
- Complement-targeted therapeuticsNature Biotechnology, 2007
- Candidate inhibitors of porcine complementMolecular Immunology, 2007
- Triggers of inflammation after renal ischemia/reperfusionClinical Immunology, 2006
- Long-term effects of acute ischemia and reperfusion injuryKidney International, 2004
- Local and Remote Ischemia-Reperfusion Injury Is Mitigated in Mice Overexpressing Human C1 InhibitorEuropean Surgical Research, 2004
- Continuous 48-h C1-inhibitor treatment, following reperfusion therapy, in patients with acute myocardial infarctionEuropean Heart Journal, 2002
- The membrane attack complex of complement induces caspase activation and apoptosisEuropean Journal of Immunology, 2002
- ComplementNew England Journal of Medicine, 2001